Replies to post #417063 on NorthWest Biotherapeutics Inc (NWBO)

[flipper44]

I suppose those contracts/agreements were entered into then?

[Sojourner55]

Newman is sending a Ruth Chris gift voucher dinner for two for digging this up :))

It took me a freaking hour to find this statement in the filings.

[exwannabe]

It does not say they working on a BLA.

It took me 1 minute of reading your reply to see it has nothing to say about them actually working on the BLA itself as being discussed in this thread.

"anticipates"

A word LP loves.

[HappyLibrarian]

This is far different from NWBO said they are doing a BLA. They never actually even use the word.

The Company is in the process of entering into expanded agreements with certain Scientific Advisory Board members... (emphasis added)

whom the Company anticipates will play important roles in helping the Company prepare for potential applications for regulatory approvals of the DCVax-L product.

This is not even saying that they have entered into any such agreements but that they are in the process.

Given that NWBO can spend a decade in the home stretch, this is not encouraging.

[Gus McCrae]

That statement was made in both the 2Q and 3Q 2020 (which was actually filed in Jan. 2021) Form 10-Qs.

Item 5 of Form 10-Q allows a reporting company to use this item to disclose things that are otherwise disclosable on Form 8-K. So...if the company thought that the fact that they were negotiating agreements with key consultants needed to be disclosed on Form 8-K, any actual agreements entered into would definitely need to be disclosed as material contracts and filed as exhibits. This has bugged me since they make these disclosures, but, I figured they hadn't actually entered into these agreements since they weren't disclosed.

Your post got me curious again so I went back through the 2Q Form 10-Q and saw that since January 1, 2021, they have issued 910,000 options at an average weighted price of $0.92 with an average remaining time period of 9.1 years. Obviously, this disclosure cannot be correct because the stock has not closed below $1.00 (yet) and only 6 months had passed at that time...so these options must have actually been granted sometime in the fall of 2020, and they likely went to the "key consultants," which raised ANOTHER disclosure issue, since these agreements cannot credibly be argued to not be material. Their own Item 5 Form 10-Q disclosures tell us they know they are material.

So, the good news is that they probably have retained some key consultants who might currently be helping prepare for potential applications. The bad news is, we really can't say for sure because the company has been so sketchy/misleading with its disclosures.

[MI Dendream]

Senti, Thank you for devoting your time to explore the depth of the SEC filings to try to answer my request and ease my mind. My reading is similar to your, and I don’t want to be snarky, but it stops short of being satisfying.

Thank you anyway and I appreciate your contributions